The recent rally in drug stocks has propelled the Dow and S&P 500 to record highs, showcasing investor confidence despite concerns over a potential government shutdown. This surge highlights the resilience of the market and the importance of the pharmaceutical sector in driving economic growth. As investors remain optimistic, they may soon need to address the implications of missing economic data, which could shift their focus in the near future.

The stock market saw a significant boost today, with the S&P 500 reaching a record high following the recent government shutdown. This surge is largely attributed to gains in drug stocks, which have performed well despite a surprising contraction in private-sector payrolls last month. This development is important as it reflects investor confidence and resilience in certain sectors, even amidst broader economic challenges.